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Background
Treatment of CSF shunts with antimicrobial agents has
shown great potential for preventing shunt infections.
Providing a longer period of sustained antibiotic release is
an important challenge to the development of clinical
shunts for long-term implantation. This study aimed to
evaluate the long-term in vitro drug release performance of
cast-molded catheters with self-assembled silane monol-
ayer coatings to provide a tuneable release rate.
Materials and methods
A cast molding approach was used to load rifampicin into
the silicone precursor prior to curing. Self-assembled per-
fluorodecyltrichlorosilane (FAS) and octadecyltrichlorosi-
lane (OTS) monolayers and FAS multilayers were
deposited on the drug-loaded silicone surface by chemical
vapor deposition and molecular vapor deposition, respec-
tively. The morphology of adhered bacteria was observed
by scanning electron microscopy and atomic force micro-
scopy. The antibiotic release rate was determined by UV
spectrometry. The efficacy of the rifampicin was deter-
mined by measurement of S. epidermidis adhesion on
treated and untreated silicone surfaces using a colony
counting method.
Results
The cast molding approach avoided the microstructural
changes and minimized the initial "burst effect" com-
pared with the diffusion-controlled technique. Com-
pacted multilayered structures and sparsely-dispersed,
single-layered structures of S epidermidis colonization
were observed on untreated silicone surfaces and
rifampicin-loaded silicone surfaces, respectively. Defor-
mation of the Staphylococcus epidermidis cells was
observed. Sustained in vitro release from rifampicin-
loaded silicone for at least 110 days at a level of approxi-
mately 2–4 μg/cm2-day was achieved. The rifampicin-
loaded silicone decreased bacterial adherence by 99.8%
on fresh 8.3% rifampicin-loaded silicone and by 94.8%
on rifampicin-loaded eluted silicone. Additionally, FAS
multilayers were effective in moderating the burst effect
and achieving a longer-term delivery compared with FAS
and OTS monolayers.
Conclusion
Incorporation of antibiotics into shunt catheters has been
accomplished by others. However, the surfactant used in
Cook Spectrum catheters to bind minocycline is toxic to
nervous tissue, and drug release from Bactiseal™ catheters
is reported to be only 28 days. Combining molecular
vapor deposition of FAS or OTS with cast molding
impregnation of rifampicin into silicone, we have pro-
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longed drug release well beyond this time. Moreover, it
was demonstrated that the FAS coatings are effective in
controlling and tuning the drug release rate. Cast molding
can be adapted to a host of pharmacologically active
ingredients or combinations as desired and be applied to
a variety of shunt-based drug release treatments. This
novel coating approach can also create different designs
for surface coatings to customize and tailor the delivery
rates for specific patients.Page 2 of 2
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